TELADOC HEALTH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
TELADOC HEALTH, INC. (TDOC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 3.90% for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-26.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2024-04-26
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-03-31 was 3.90%.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2021-03-31 was 0.51%.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2016 was 2.29%, a 11.17% increase from fiscal 2015.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2015 was 2.06%, a 10.43% decline from fiscal 2014.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2014 was 2.30%, a 4.07% increase from fiscal 2013.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2013 was 2.21%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|
| 2024-03-31 | 3.90% 10-Q · filed 2024-04-26 | |||
| 2023-09-30 | 4.34% 10-Q · filed 2023-10-27 | |||
| 2023-06-30 | 4.08% 10-Q · filed 2023-07-28 | |||
| 2022-09-30 | 3.46% 10-Q · filed 2023-10-27 | |||
| 2022-06-30 | 2.89% 10-Q · filed 2023-07-28 | |||
| 2021-09-30 | 0.70% 10-Q · filed 2021-11-01 | |||
| 2021-06-30 | 0.65% 10-Q · filed 2021-08-02 | |||
| 2021-03-31 | 0.51% 10-Q · filed 2021-05-03 | |||
| 2016-12-31 | 2.29% 10-K · filed 2017-03-01 | |||
| 2015-12-31 | 2.06% 10-K · filed 2017-03-01 | |||
| 2014-12-31 | 2.30% 10-K · filed 2017-03-01 | |||
| 2013-12-31 | 2.21% 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |